1. Y. W. Chien. Advances in transdermal systemic medication. In Y. W. Chien (ed.), Transdermal Controlled Systemic Medications, Marcel Dekker, New York, 1987, pp. 1–22.
2. B. W. Barry. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci.
14:101–114 (2001).
3. G. K. McEvoy. Diltiazem hydrochloride. In G. K. McEvoy, E. K. Snow, L. Kester, J. Miller, O. H. Welsh, and K. Litvak (eds.), AHFS Drug Information, American Society of Health-System Pharmacists, Bethesda, 2005, pp. 1835–1842.
4. D. J. Mazzo, C. L. Obetz, and J. Shuster. Diltiazem Hydrochloride. Analytical Profiles of Drug Substances, Vol. 23, Academic Press, California, 1994, pp. 53–98.
5. P. R. Rao and P. V. Diwan. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev. Ind. Pharm.
244:327–336 (1998).